The potential effect of Annona muricata and Cisplatin as antioxidant and antitumor in rat with liver cancer by induction of apoptosis through P13K AKT signaling pathway
Zein, N., Yassin, F., Hassan, A. (2023). The potential effect of Annona muricata and Cisplatin as antioxidant and antitumor in rat with liver cancer by induction of apoptosis through P13K \ AKT signaling pathway. EKB Journal Management System, 19(1), 37-51. doi: 10.21608/blj.2023.314428
Nabila Zein; Fathy Yassin; Amira Hassan. "The potential effect of Annona muricata and Cisplatin as antioxidant and antitumor in rat with liver cancer by induction of apoptosis through P13K \ AKT signaling pathway". EKB Journal Management System, 19, 1, 2023, 37-51. doi: 10.21608/blj.2023.314428
Zein, N., Yassin, F., Hassan, A. (2023). 'The potential effect of Annona muricata and Cisplatin as antioxidant and antitumor in rat with liver cancer by induction of apoptosis through P13K \ AKT signaling pathway', EKB Journal Management System, 19(1), pp. 37-51. doi: 10.21608/blj.2023.314428
Zein, N., Yassin, F., Hassan, A. The potential effect of Annona muricata and Cisplatin as antioxidant and antitumor in rat with liver cancer by induction of apoptosis through P13K \ AKT signaling pathway. EKB Journal Management System, 2023; 19(1): 37-51. doi: 10.21608/blj.2023.314428

The potential effect of Annona muricata and Cisplatin as antioxidant and antitumor in rat with liver cancer by induction of apoptosis through P13K \ AKT signaling pathway

Biochemistry Letters
Volume 19, Issue 1, 2023, Page 37-51  XML PDF (849.4 K)
Document Type: Original Article
DOI: 10.21608/blj.2023.314428
View on SCiNiTO View on SCiNiTO
Authors
Nabila Zein1; Fathy Yassin2; Amira Hassan1
1Biochemistry Department, Faculty of Science, Zagazig University
2Chemistry Department, Faculty of Science, Zagazig University
Abstract
Objective: The aim of this study was to investigate the effects of Cisplatin and Annona muricata's efficacy, safety, and tolerability in treating liver cancer in rats. Method: Animals: 56 male albino rats, 3–4 months old, weighing 180–200 g on average, were purchased and brought to the animal house at the Department of Biochemistry Faculty of Science, Zagazig University. Rats used in the experiment were split into 4 groups, as follows: 14 healthy rats in Group (1) are left untreated (Negative Control). 42 healthy rats were separated into three equal groups, after receiving an IP dose of CCl4 (1 ml/kg/ twice a week for 8 weeks) to induce HCC. Group (2) consists of 14 rats with liver cancer which were not treated (Positive control). Group (3) has 14 liver cancer-afflicted rats, received IP dose of Cisplatin (6 mg/kg/week for 4 weeks). Group (4) has 14 liver cancer-afflicted rats that were given oral dose of Annona muricata (300 mg/kg every day for 4 weeks). Results: At the end of experiment blood samples were taken from all rats in all groups to preserve the serum for estimation of serum liver enzymes (AST, ALT and ALP), Serum proteins (total protein, albumin, globulin and A/G ratio), serum kidney function tests (urea and creatinine) and inflammatory marker (TNF-α). Liver tissues were collected for gene expression determination of PI3K and Akt levels and histopathological study. Conclusion: The present study indicates that Annona muricata gives significant results in treatment of Albino rats with liver cancer, due to its antioxidant, anti-inflammatory and anticancer effects beside improvements of hepatorenal cellular, so we should interest in research in the same field with conducting experiments using Annona muricata as a protective agent for the liver against cancer.
Keywords
CCl4; Cisplatin; Annona muricata; liver cancer and histopathology
Statistics
Article View: 84
PDF Download: 81